What is the best course of treatment for a 37-year-old male with a recurrent urinary tract infection (UTI) due to Group B streptococcus (GBS), previously treated with amoxicillin (amoxicillin), now presenting with urinary frequency and painful urination?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Recurrent Group B Streptococcus UTI in Adult Male

For a 37-year-old male with recurrent Group B streptococcus UTI symptoms after initial treatment with amoxicillin, a 7-day course of trimethoprim-sulfamethoxazole is recommended as the most effective treatment option.

Diagnosis Confirmation

Before initiating treatment, it's essential to confirm the recurrence:

  • Obtain a urine culture to confirm the diagnosis and determine antimicrobial susceptibility 1
  • Assess for potential complicating factors, as UTIs in males are generally considered complicated 1, 2
  • Evaluate for underlying structural or functional abnormalities that may contribute to recurrence

Treatment Approach

First-line Treatment

  1. Antimicrobial therapy:

    • Trimethoprim-sulfamethoxazole (160/800 mg twice daily for 7 days) is the recommended treatment for UTIs in men 1
    • This is preferred over amoxicillin for recurrent infection, as the initial treatment failure suggests possible resistance
  2. Treatment duration:

    • 7-day course is recommended for males with UTI 1
    • Extended treatment (up to 14 days) may be considered if prostatitis cannot be excluded 1

Alternative Options

If trimethoprim-sulfamethoxazole is contraindicated or if susceptibility testing indicates resistance:

  • Fluoroquinolones can be prescribed based on local susceptibility patterns 1
  • Nitrofurantoin is not recommended for males due to poor prostatic penetration
  • Cephalosporins may be considered if susceptibility testing supports their use 1

Evaluation for Underlying Causes

Unlike in women under 40, males with UTI warrant further evaluation:

  • Consider urological evaluation to identify structural abnormalities 2
  • Assess for potential risk factors including:
    • Urinary obstruction
    • Incomplete bladder emptying
    • Diabetes mellitus
    • Immunosuppression
    • Recent instrumentation 2

Prevention Strategies

After treating the acute episode, implement preventive measures:

  • Increased fluid intake to reduce risk of recurrence 2
  • Consider methenamine hippurate (1g twice daily) for non-antibiotic prophylaxis 2
  • For recurrent infections despite these measures, consider:
    • Low-dose continuous antimicrobial prophylaxis for 6-12 months
    • Post-coital antimicrobial prophylaxis if infections are related to sexual activity 2

Clinical Pearls and Pitfalls

  • Male UTIs are complicated: All UTIs in males are considered complicated and require more thorough evaluation than in females 1, 2
  • Group B streptococcus considerations: While E. coli is the most common UTI pathogen, Group B streptococcus can cause persistent infections and may require different treatment approaches 3, 4
  • Avoid treatment failure: Do not repeat the same antibiotic (amoxicillin) that failed initially 1
  • Duration matters: Shorter courses (<7 days) may lead to treatment failure in males 1
  • Follow-up: Ensure symptoms resolve completely; persistent symptoms warrant further investigation for potential abscess formation or prostatitis 3

By following this structured approach, recurrent Group B streptococcus UTI can be effectively managed while minimizing the risk of further recurrences and complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Recurrent Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.